Sign up to receive our free report:
How to profit from the most
explosive sector in the world...
E-mail address:

This week, we're focusing on one of the most explosive sectors in the world... biotechnology.

Successfully speculating in biotech takes a great deal of expertise. Buying the right stock here can literally mean never having to work again, while haphazardly choosing stocks means almost certain losses.

To get an expert's take on safely profiting from this high-risk, high-reward sector, we sat down with Casey Research's resident technology guru Alex Daley.

Alex is senior editor of Casey's Extraordinary Technology, and one of the most knowledgeable tech investors we know. He is a former insider at one of the world's largest tech companies... He's been a frequent guest on CNN, CNBC, BBC, and more... He's even on a first-name basis with billionaire Microsoft founder Bill Gates.

In this exclusive interview, you'll read about the most important trends in biotech today, and learn some of Alex's strategies for uncovering some of the world's most profitable biotech stocks.

When you sign up for this free report, you'll also receive The Daily Crux Home Delivery.

Each day, the Crux team sifts through the top financial newspapers, magazines, journals, newsletters, blogs, shareholder letters, and research reports. We select only the most valuable news, ideas, and opinions for inclusion on the Crux website. Home Delivery puts it all in your inbox.

No spam pledge: While we'll occasionally send you information about research we think you might be interested in, we will never rent or sell your e-mail address to anyone for any reason.

© 2013 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202.